Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerBilling CodesAllergy Testing ProceduresCPT cpt-95024-allergy-skin-testing-interpretation-report
    Ask Trek AI about this page

    CPT 95024: Percutaneous Allergy Skin Testing with Interpretation and Report

    Medicare pays $8 and commercial payers pay $48 on average nationally for this procedure.

    CPT code 95024 describes percutaneous allergy skin testing (skin prick/scratch) where the provider introduces allergenic extracts into the skin, observes and interprets immediate hypersensitivity responses, and documents results in a written report specifying the number of tests; this service is an allergy diagnostic test typically performed in an allergy clinic or outpatient office setting and involves direct patient contact for testing and result interpretation.

    For related coverage guidance, see recent payer policy updates: Allergen Subcutaneous Immunotherapy (SCIT), Allergy Testing, Including Selected Blood, Serum and Cellular Testing and Toxicity Testing Corporate Medical Policy, Allergy and Sensitivity Tests of Uncertain Efficacy.

    Customize your policy alerts

    Sign up for cpt 95024 policy alerts

    Get alerted when payer policies referencing 95024 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    National Reimbursement Benchmarks

    National averages show notable separation: Medicare’s mean of $8 versus BUCA’s mean commercial of $48.4 highlights that commercial payers on average reimburse substantially more than the federal program for CPT 95024. Blue Cross Blue Shield and Aetna have higher mean values closer to the commercial side, while Cigna and UnitedHealth Group sit nearer to Medicare’s level. Dispersion varies across payers. Aetna displays the widest interquartile spread (P75–P25 = $94.0–$7.0 = $87.0), indicating greater variability in allowed rates, while Blue Cross Blue Shield is comparatively tight (P75–P25 = $75.4–$46.8 = $28.6). UnitedHealth Group shows moderate spread ($12.8–$2.9 = $9.9), and Cigna’s spread is relatively small ($10.8–$1.4 = $9.4). BUCA’s interquartile span ($60.1–$28.4 = $31.7) is closer to commercial variability than to Medicare’s very narrow quartiles (P75–P25 = $8–$7 = $1).

    Table of contents

    Progress1 / 9

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools
    National Payer Mean Reimbursement Rates

    State Reimbursement Rates

    State: Alaska1 / 51

    Rate by payer

    Clinical & Coding Specifications

    Clinical Context

    A 28-year-old patient presents to an Allergy & Immunology clinic with seasonal worsening of nasal congestion, sneezing, and intermittent itchy, red eyes despite conservative measures. The clinician suspects IgE-mediated allergic rhinitis and allergic conjunctivitis and decides to perform immediate-type skin testing using percutaneous and/or intracutaneous allergen extracts to identify specific triggers. The workflow: the patient history and medication review are completed; antihistamines and interfering medications are withheld per protocol; informed consent is obtained; skin is prepared (usually forearm or back); a series of 95024 intradermal tests are administered with labeled sites; a positive control (histamine) and negative control (saline) are included; reactions are read at the specified interval; the provider interprets the immediate wheal-and-flare responses, documents the number of tests performed, provides a written report with interpretation and clinical recommendations for avoidance or consideration of immunotherapy, and communicates results to the referring clinician. Typical encounter length varies from 15–60 minutes depending on number of tests and patient counseling. Typical sites of service are outpatient Allergy & Immunology clinics, hospital outpatient departments, and ambulatory surgical centers when indicated for complex testing or when monitoring for systemic reactions is required. The service type is diagnostic skin testing (intradermal) for immediate allergic response, with interpretation and documented report using 95024.

    Related CPT Codes

    CPT CodeDescriptionRelationship to This Procedure

    Related Modifiers

    9 rows

    ModifierDescriptionWhen to Use
    25CPT modifier 25 indicates that on the same day as another procedure or service, the same physician or other qualified health care professional provided a significant, separately identifiable…- When to apply: Use modifier 25 only on an E/M code to indicate the same provider delivered a significant, separately identifiable E/M service on the same day as another procedure or service — i.e.,…
    26Modifier 26 (Professional Component) identifies and bills only the professional portion of a split service — the physician’s interpretation, report, and medical judgment — when the technical…- Use CPT Modifier -26 when you are billing only the professional component (PC) of a split‑bill eligible service—i.e., you performed the physician interpretation, medical judgment and prepared a…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…
    76Modifier -76, Repeat Procedure or Service by Same Physician or Other Qualified Health Care Professional, is appended when the same provider performs an identical, medically necessary procedure or…- Use modifier -76 when the same physician or other qualified health care professional performs an identical procedure or service a second (or subsequent) time on the same date of service and the…
    77Modifier 77 indicates that a previously performed procedure or service was legitimately repeated by a different physician or other qualified health care professional. The AMA’s CPT definition…- Use modifier 77 when a basic procedure or service already performed is repeated by a different physician or other qualified health care professional (for example, a second provider independently…
    52Modifier ‑52 (Reduced Services) indicates that a service or procedure was partially reduced or omitted at the provider’s discretion, allowing reporting of the basic procedure number with a qualifier…- Use modifier -52 when a physician or qualified health professional electively reduces or omits part of a procedure or service (for example, performing fewer required views or omitting a portion of…
    53Modifier 53 (Discontinued Procedure) signals that a surgical or diagnostic service was begun by the physician but terminated because of extenuating circumstances that threatened the patient’s…- Use modifier -53 when a physician/qualified healthcare professional has started a surgical or diagnostic procedure (e.g., anesthesia administered, incision or scope insertion) and then discontinues…
    22Modifier –22 (Increased Procedural Services) is used when a reported procedure is substantially more extensive than normally required. The CPT Manual and CMS state it may be appended only when the…- When to use: Append modifier -22 to a procedural CPT code when the service performed is substantially more extensive than the usual service described by that code — i.e., the procedure required…
    78CPT modifier -78 indicates an unplanned, related return to the operating or procedure room by the same provider during the global postoperative period. It is appended when treatment for a…- Use modifier -78 when an unplanned, related complication during the original procedure’s global postoperative period requires the patient to return to a formal operating or procedure room and the…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    207K00000X
    207RA0201X
    207RI0008X
    261QM0855X
    152WS0006X
    2472D0500X
    310400000X
    1835C0207X

    Related ICD-10-CM Codes

    19 rows

    ICD-10-CM CodeDescription
    H10.11Acute atopic conjunctivitis, right eye
    H10.12Acute atopic conjunctivitis, left eye
    H10.13Acute atopic conjunctivitis, bilateral
    H10.411Chronic giant papillary conjunctivitis, right eye
    H10.412Chronic giant papillary conjunctivitis, left eye
    H10.413Chronic giant papillary conjunctivitis, bilateral
    H10.419Chronic giant papillary conjunctivitis, unspecified eye
    H10.44Vernal conjunctivitis
    H10.45Other chronic allergic conjunctivitis
    J30.0Vasomotor rhinitis

    Showing 1–10 of 19

    Related Payer Policy Updates

    Specialty: Allergy/Clinical Immunology1 / 3

    10 rows

    PolicyPayerEffective Date
    Allergen Subcutaneous Immunotherapy (SCIT)Providence Health Plan2026-11-01
    Allergy Testing, Including Selected Blood, Serum and Cellular Testing and Toxicity Testing Corporate Medical Policybcbsvermont2026-11-01
    Allergy and Sensitivity Tests of Uncertain Efficacyregence2026-10-01
    Allergy Testing and InjectionsUnitedHealthcare2026-10-01
    Allergy TestingProvidence Health Plan2026-10-01
    Diagnosis of Idiopathic Environmental IntoleranceOscar Health2026-10-01
    Allergen Testingblue cross blue shield - louisiana2026-09-15
    Allergen TestingBlue Cross Blue Shield - New Mexico2026-09-04
    Allergen Immunotherapymarylandphysicianscarempc2026-09-01
    ALLERGY TESTING / IMMUNOTHERAPYpriority_health_medicare2026-09-01

    Related Codes

    CPT-95004-PERCUTANEOUS-ALLERGEN-SKIN-TEST

    CPT 95004: Percutaneous (Skin Prick) Allergy Test

    CPT-95012-EXHALED-NITRIC-OXIDE-FE-NO-TESTING-FOR-AIRWAY-INFLAMMATION

    CPT 95012: Exhaled Nitric Oxide Measurement for Airway Inflammation

    CPT-95017-ALLERGY-SKIN-TESTING-SEQUENTIAL-INTRADERMAL-PRICK

    CPT 95017: Allergy Skin Testing (Scratch/Prick/Puncture/Intradermal)

    CPT-95018-SEQUENTIAL-INCREMENTAL-DRUG-BIOLOGIC-SKIN-TEST

    CPT 95018: Sequential Incremental Skin Test for Immediate Allergy

    CPT-95027-AIRBORNE-ALLERGEN-SKIN-PRICK-TESTING-INTERPRETATION

    CPT 95027: Allergen Skin-Prick Testing with Airborne Extracts

    CPT-95028-ALLERGY-DELAYED-SKIN-TEST-INTERPRETATION-REPORT

    CPT 95028: Delayed Allergic Skin Test, Interpretation and Report

    CPT-95044-PATCH-TEST-ALLERGIC-REACTION

    CPT 95044: Patch Testing for Contact Allergy

    CPT-95052-PHOTO-PATCH-TESTING-WITH-PATCH-TEST

    CPT 95052: Allergenic Extract Photo Patch Test

    CPT-95056-PHOTO-TEST-ALLERGENIC-EXTRACT-PHOTODERMATITIS

    CPT 95056: Allergenic Extract Photo Test for Photosensitive Allergy

    CPT-95060-OCULAR-ALLERGY-TESTING-TECHNICAL

    CPT 95060: Ophthalmic Allergy Testing, Technical Component

    Showing 1–10 of 12

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    95004Percutaneous (scratch, puncture, or prick) tests with allergenic extracts; immediate type reaction, specify number of testsOften performed as the initial screening method; less invasive than 95024 and used when multiple quick tests are desired
    95027Intracutaneous (intradermal) tests, sequential and incremental, with allergenic extracts for airborne allergens, immediate type reaction, specify number of testsClosely related technique; 95027 describes sequential/incremental intradermal testing for airborne allergens and may be used in conjunction or as an alternative to 95024 depending on protocol
    95028Intracutaneous (intradermal) tests with allergenic extracts, delayed type reaction, including reading, specify number of testsUsed when delayed (type IV) hypersensitivity readings are required in addition to immediate readings covered by 95024